{
  "input": {
    "mode": "execute_actions",
    "query": {
      "entity": "Hyperammonaemia",
      "relation": "contraindication"
    },
    "items": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "高氨血症的风险",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "高氨血症的风险",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H3",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "高氨血症的风险",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H4",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "高氨血症的风险",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ]
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "n_valproic_acid",
          "type": "Drug",
          "label": "Valproic Acid",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_topiramate",
          "type": "Drug",
          "label": "Topiramate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_carnitine",
          "type": "Drug",
          "label": "Carnitine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_lactulose",
          "type": "Drug",
          "label": "Lactulose",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_sodium_benzoate",
          "type": "Drug",
          "label": "Sodium Benzoate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_nitroprusside",
          "type": "Drug",
          "label": "Nitroprusside",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_phenobarbital",
          "type": "Drug",
          "label": "Phenobarbital",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_benzodiazepines",
          "type": "Drug",
          "label": "Benzodiazepines",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_asparaginase",
          "type": "Drug",
          "label": "Asparaginase",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_amino_acids",
          "type": "Drug",
          "label": "Amino Acids",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_hyperammonaemia",
          "type": "Disease",
          "label": "Hyperammonaemia",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot",
          "type": "Target",
          "label": "OffTargetHyperammonaemia",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp",
          "type": "Pathway",
          "label": "RiskPathwayHyperammonaemia",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv",
          "type": "Phenotype",
          "label": "AdversePhenotypeHyperammonaemia",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "edges": [
        {
          "source": "n_valproic_acid",
          "target": "n_hyperammonaemia",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知对氨基酸代谢影响"
        },
        {
          "source": "n_topiramate",
          "target": "n_hyperammonaemia",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与尿素循环干扰相关"
        },
        {
          "source": "n_carnitine",
          "target": "n_hyperammonaemia",
          "relation": "modulates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "支持脂肪酸代谢，可能降低氨基酸积累"
        },
        {
          "source": "n_lactulose",
          "target": "n_hyperammonaemia",
          "relation": "modulates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "有助于降低血氨"
        },
        {
          "source": "n_sodium_benzoate",
          "target": "n_hyperammonaemia",
          "relation": "modulates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "通过结合氨降低氨水平"
        },
        {
          "source": "n_nitroprusside",
          "target": "n_hyperammonaemia",
          "relation": "inhibits",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "可用于激活硝酸盐通路"
        },
        {
          "source": "n_phenobarbital",
          "target": "n_hyperammonaemia",
          "relation": "causes",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "可能加重肝脏代谢负担"
        },
        {
          "source": "n_benzodiazepines",
          "target": "n_hyperammonaemia",
          "relation": "causes",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "可能导致神经毒性风险"
        },
        {
          "source": "n_methotrexate",
          "target": "n_hyperammonaemia",
          "relation": "causes",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "可能影响氨基酸代谢"
        },
        {
          "source": "n_asparaginase",
          "target": "n_hyperammonaemia",
          "relation": "causes",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "抑制氨基酸合成，可能增加氨"
        },
        {
          "source": "n_amino_acids",
          "target": "n_hyperammonaemia",
          "relation": "causes",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "直接增加氨的来源"
        },
        {
          "source": "n_corticosteroids",
          "target": "n_hyperammonaemia",
          "relation": "causes",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "可能影响氨代谢"
        },
        {
          "source": "n_valproic_acid",
          "target": "n_hyperammonaemia",
          "relation": "contraindicates",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "已知导致氨水平上升"
        },
        {
          "source": "n_topiramate",
          "target": "n_hyperammonaemia",
          "relation": "contraindicates",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "与高氨血症相关"
        },
        {
          "source": "n_carnitine",
          "target": "n_hyperammonaemia",
          "relation": "contraindicates",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响氨代谢"
        },
        {
          "source": "n_lactulose",
          "target": "n_hyperammonaemia",
          "relation": "contraindicates",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "干预氨的吸收"
        },
        {
          "source": "n_sodium_benzoate",
          "target": "n_hyperammonaemia",
          "relation": "contraindicates",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "可能增加氨产生"
        },
        {
          "source": "n_nitroprusside",
          "target": "n_hyperammonaemia",
          "relation": "contraindicates",
          "weight": 0.65,
          "agent": "Skeptic",
          "rationale": "风险机制未明确"
        },
        {
          "source": "n_phenobarbital",
          "target": "n_hyperammonaemia",
          "relation": "contraindicates",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "影响肝功能"
        },
        {
          "source": "n_benzodiazepines",
          "target": "n_hyperammonaemia",
          "relation": "contraindicates",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "有潜在抑制作用"
        },
        {
          "source": "n_methotrexate",
          "target": "n_hyperammonaemia",
          "relation": "contraindicates",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "与氨代谢冲突"
        },
        {
          "source": "n_asparaginase",
          "target": "n_hyperammonaemia",
          "relation": "contraindicates",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "作用机制可能加剧风险"
        },
        {
          "source": "n_amino_acids",
          "target": "n_hyperammonaemia",
          "relation": "contraindicates",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "氨的潜在来源"
        },
        {
          "source": "n_corticosteroids",
          "target": "n_hyperammonaemia",
          "relation": "contraindicates",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "平衡代谢可能失调"
        },
        {
          "source": "n_hyperammonaemia",
          "target": "n_ot",
          "relation": "associated_with",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "与高氨血症间关系明显"
        },
        {
          "source": "n_ot",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能的旁路机制"
        },
        {
          "source": "n_rp",
          "target": "n_adv",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "低效能效应可造成不良表型"
        },
        {
          "source": "n_adv",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "高氨血症的风险抵消潜在收益"
        },
        {
          "source": "n_adv",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "高氨血症的风险抵消潜在收益"
        },
        {
          "source": "n_adv",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "高氨血症的风险抵消潜在收益"
        },
        {
          "source": "n_adv",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "高氨血症的风险抵消潜在收益"
        },
        {
          "source": "n_adv",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "高氨血症的风险抵消潜在收益"
        },
        {
          "source": "n_adv",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "高氨血症的风险抵消潜在收益"
        },
        {
          "source": "n_adv",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "高氨血症的风险抵消潜在收益"
        },
        {
          "source": "n_adv",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "高氨血症的风险抵消潜在收益"
        },
        {
          "source": "n_adv",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "高氨血症的风险抵消潜在收益"
        },
        {
          "source": "n_adv",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "高氨血症的风险抵消潜在收益"
        },
        {
          "source": "n_adv",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "高氨血症的风险抵消潜在收益"
        },
        {
          "source": "n_adv",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "高氨血症的风险抵消潜在收益"
        }
      ],
      "round_index": 4
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "hypothesis_id": "H1",
    "executed_actions": [
      {
        "action_ref": 0,
        "status": "done",
        "graph_updates": {
          "add_nodes": [
            {
              "id": "n_ot",
              "type": "Target",
              "label": "OffTargetHyperammonaemia",
              "attrs": {
                "agent": "Skeptic"
              }
            },
            {
              "id": "n_rp",
              "type": "Pathway",
              "label": "RiskPathwayHyperammonaemia",
              "attrs": {
                "agent": "Skeptic"
              }
            },
            {
              "id": "n_adv",
              "type": "Phenotype",
              "label": "AdversePhenotypeHyperammonaemia",
              "attrs": {
                "agent": "Skeptic"
              }
            }
          ],
          "add_edges": [
            {
              "source": "n_hyperammonaemia",
              "target": "n_ot",
              "relation": "associated_with",
              "weight": 0.85,
              "agent": "Skeptic",
              "rationale": "与高氨血症间关系明显"
            },
            {
              "source": "n_ot",
              "target": "n_rp",
              "relation": "involved_in",
              "weight": 0.8,
              "agent": "Skeptic",
              "rationale": "可能的旁路机制"
            },
            {
              "source": "n_rp",
              "target": "n_adv",
              "relation": "causes",
              "weight": 0.85,
              "agent": "Skeptic",
              "rationale": "低效能效应可造成不良表型"
            },
            {
              "source": "n_adv",
              "target": "H1",
              "relation": "refutes",
              "weight": 0.9,
              "agent": "Skeptic",
              "rationale": "高氨血症的风险抵消潜在收益"
            },
            {
              "source": "n_adv",
              "target": "H2",
              "relation": "refutes",
              "weight": 0.9,
              "agent": "Skeptic",
              "rationale": "高氨血症的风险抵消潜在收益"
            },
            {
              "source": "n_adv",
              "target": "H3",
              "relation": "refutes",
              "weight": 0.9,
              "agent": "Skeptic",
              "rationale": "高氨血症的风险抵消潜在收益"
            },
            {
              "source": "n_adv",
              "target": "H4",
              "relation": "refutes",
              "weight": 0.9,
              "agent": "Skeptic",
              "rationale": "高氨血症的风险抵消潜在收益"
            }
          ],
          "merge": [],
          "set_weights": [],
          "conflict_hotspots": [
            {
              "topic": "高氨血症的风险",
              "pro_nodes": [
                "n_valproic_acid",
                "n_topiramate"
              ],
              "con_nodes": [
                "n_adv"
              ],
              "note": "高氨血症的风险可能抵消潜在的治疗效益"
            }
          ]
        },
        "notes": "已完成对高氨血症的安全性压力测试：以高权重 refutes 边连到假设"
      }
    ],
    "unexecuted_actions": [],
    "residual_conflicts": [
      "高氨血症与其他药物的相互作用及潜在风险仍需进一步评估"
    ]
  }
}